Clinical Trial Update: Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [Phase 2]

View source ↗

Summary

A Phase II trial of Carmustine, Streptozocin, and Mercaptopurine for refractory or recurrent brain neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Oligoastrocytoma

Drugs mentioned

• BiCNU (carmustine)
• Purinethol (6-mercaptopurine)
• Zanosar (streptozocin)

Snippet

Sponsor: Emory University | Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 2 | Status: COMPLETED